7654728

Source:http://linkedlifedata.com/resource/pubmed/id/7654728

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0002335, umls-concept:C0004048, umls-concept:C0018823, umls-concept:C0028128, umls-concept:C0033567, umls-concept:C0037533, umls-concept:C0042402, umls-concept:C0087111, umls-concept:C0348016, umls-concept:C1280500
pubmed:issue	3
pubmed:dateCreated	1995-10-5
pubmed:abstractText	Vasodilator therapy is frequently needed to treat pulmonary hypertension after heart transplantation. In the present study, the effects of intravenous sodium nitroprusside, prostacyclin, prostaglandin E1, and inhaled nitric oxide (5, 10, and 20 parts per million) on central hemodynamics, right ventricular function, and pulmonary selectivity were evaluated shortly after heart transplantation.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9102703
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Alprostadil, http://linkedlifedata.com/resource/pubmed/chemical/Epoprostenol, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide, http://linkedlifedata.com/resource/pubmed/chemical/Nitroprusside, http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents
pubmed:status	MEDLINE
pubmed:issn	1053-2498
pubmed:author	pubmed-author:Kieler-JensenNN, pubmed-author:LundinSS, pubmed-author:RickstenS ESE
pubmed:issnType	Print
pubmed:volume	14
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	436-43
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:7654728-Administration, Inhalation, pubmed-meshheading:7654728-Adolescent, pubmed-meshheading:7654728-Adult, pubmed-meshheading:7654728-Alprostadil, pubmed-meshheading:7654728-Blood Pressure, pubmed-meshheading:7654728-Cardiac Output, pubmed-meshheading:7654728-Epoprostenol, pubmed-meshheading:7654728-Female, pubmed-meshheading:7654728-Heart Transplantation, pubmed-meshheading:7654728-Hemodynamics, pubmed-meshheading:7654728-Humans, pubmed-meshheading:7654728-Hypertension, Pulmonary, pubmed-meshheading:7654728-Infusions, Intravenous, pubmed-meshheading:7654728-Male, pubmed-meshheading:7654728-Middle Aged, pubmed-meshheading:7654728-Nitric Oxide, pubmed-meshheading:7654728-Nitroprusside, pubmed-meshheading:7654728-Pulmonary Circulation, pubmed-meshheading:7654728-Stroke Volume, pubmed-meshheading:7654728-Vascular Resistance, pubmed-meshheading:7654728-Vasodilator Agents, pubmed-meshheading:7654728-Ventricular Function, Right
pubmed:articleTitle	Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
pubmed:affiliation	Department of Anesthesia and Intensive Care, Sahlgren's Hospital, University of Gothenburg, Sweden.
pubmed:publicationType	Journal Article, Comparative Study, Research Support, Non-U.S. Gov't